Annual Cash & Cash Equivalents
$83.55 M
-$18.19 M-17.88%
December 31, 2023
Summary
- As of February 6, 2025, LUNG annual cash & cash equivalents is $83.55 million, with the most recent change of -$18.19 million (-17.88%) on December 31, 2023.
- During the last 3 years, LUNG annual cash & cash equivalents has fallen by -$148.01 million (-63.92%).
- LUNG annual cash & cash equivalents is now -63.92% below its all-time high of $231.56 million, reached on December 31, 2020.
Performance
LUNG Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$63.31 M
-$152.00 K-0.24%
September 30, 2024
Summary
- As of February 6, 2025, LUNG quarterly cash and cash equivalents is $63.31 million, with the most recent change of -$152.00 thousand (-0.24%) on September 30, 2024.
- Over the past year, LUNG quarterly cash and cash equivalents has dropped by -$20.23 million (-24.22%).
- LUNG quarterly cash and cash equivalents is now -72.66% below its all-time high of $231.56 million, reached on December 31, 2020.
Performance
LUNG Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LUNG Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.9% | -24.2% |
| 3 y3 years | -63.9% | -24.2% |
| 5 y5 years | +1925.9% | -24.2% |
LUNG Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -43.7% | at low | -57.4% | at low |
| 5 y | 5-year | -63.9% | +465.8% | -72.7% | +328.7% |
| alltime | all time | -63.9% | +1925.9% | -72.7% | +328.7% |
Pulmonx Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $63.31 M(-0.2%) |
| Jun 2024 | - | $63.46 M(-9.5%) |
| Mar 2024 | - | $70.16 M(-16.0%) |
| Dec 2023 | $83.55 M(-17.9%) | $83.55 M(-12.0%) |
| Sep 2023 | - | $94.94 M(-6.5%) |
| Jun 2023 | - | $101.58 M(-8.0%) |
| Mar 2023 | - | $110.41 M(+8.5%) |
| Dec 2022 | $101.74 M | $101.74 M(-9.5%) |
| Sep 2022 | - | $112.40 M(-7.8%) |
| Jun 2022 | - | $121.95 M(-5.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $129.17 M(-13.0%) |
| Dec 2021 | $148.48 M(-35.9%) | $148.48 M(-21.1%) |
| Sep 2021 | - | $188.07 M(-5.3%) |
| Jun 2021 | - | $198.70 M(-5.1%) |
| Mar 2021 | - | $209.28 M(-9.6%) |
| Dec 2020 | $231.56 M(+1468.1%) | $231.56 M(+481.7%) |
| Sep 2020 | - | $39.81 M(-8.2%) |
| Jun 2020 | - | $43.35 M(+193.5%) |
| Dec 2019 | $14.77 M(+258.1%) | $14.77 M |
| Dec 2018 | $4.12 M | - |
FAQ
- What is Pulmonx annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Pulmonx?
- What is Pulmonx annual cash & cash equivalents year-on-year change?
- What is Pulmonx quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Pulmonx?
- What is Pulmonx quarterly cash and cash equivalents year-on-year change?
What is Pulmonx annual cash & cash equivalents?
The current annual cash & cash equivalents of LUNG is $83.55 M
What is the all time high annual cash & cash equivalents for Pulmonx?
Pulmonx all-time high annual cash & cash equivalents is $231.56 M
What is Pulmonx annual cash & cash equivalents year-on-year change?
Over the past year, LUNG annual cash & cash equivalents has changed by -$18.19 M (-17.88%)
What is Pulmonx quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LUNG is $63.31 M
What is the all time high quarterly cash and cash equivalents for Pulmonx?
Pulmonx all-time high quarterly cash and cash equivalents is $231.56 M
What is Pulmonx quarterly cash and cash equivalents year-on-year change?
Over the past year, LUNG quarterly cash and cash equivalents has changed by -$20.23 M (-24.22%)